Dr. Reddy’s Laboratories Ltd announced the SEC has concluded its probe into alleged improper payments in Ukraine, with no enforcement action recommended, but future action remains possible. Shares of Dr. Reddy’s Laboratories Ltd ended marginally lower on Tuesday, February 24, by 0.57% at ₹1,300.00 on the NSE.
